TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

Lisa A Carey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.